Jiankangyuan (600380.SH): YJH-012 injection approved to conduct clinical trials.

Zh tng cijng APP Xn, jinkng yun (600380.SH) gnggo, gngs kngg zgngs lzh yo yo jtun gfn yuxin gngs (jinchng: lzh jtun) shudo guji yopn jind gunl j hkn qinf de "Yow lnchunsuyn xk tngzh sh", pzhn YJH-012 zhsh y kizhn lnchunsuyn (tngfng shyngzhng). Zhtng Caijing APP News, Health Original (600380.SH) announced that the company's controlling subsidiary Lijia Pharmaceutical Group Co., Ltd. (referred to as Lijia Group) has received the "Drug Clinical Trial Approval Notice" issued by the National Medical Products Administration, approving the clinical trial of YJH-012 injection (indication: gout).